Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Trulieve Cannabis Corp (OP: TCNNF )

4.910 -0.160 (-3.17%)
Streaming Delayed Price Updated: 3:59 PM EST, Jan 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Trulieve Cannabis Corp

< Previous 1 2 3 4 5 6 7 8 9
...
41 42 Next >
Cannabis Stock Movers For January 9, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
DEA Accused Of Bias In Cannabis Rescheduling Hearings: Weed Stocks Plummeted In 2024 As Process Drags On
DEA judge orders agency to respond to allegations of opposing marijuana rescheduling and improper communication with opponents. Cannabis stocks declined in 2024 due to concerns about DEA review. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
EXCLUSIVE: Cannabis Physician Says Surgeon General's Alcohol Cancer Risk Warning Is 'Wake-Up Call'
Surgeon general warns about alcohol's cancer risk, suggests updates to health labels. Cannabis stocks largely rise while alcohol stocks drop. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
7 Magnificent Stocks That Can Double Your Money in 2025
Triple-digit returns may be just a click of the buy button away. 
Via The Motley Fool
Bullish Wednesday For Marijuana Stocks - Cara Therapeutics, MPX International Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
The Price Is Right: This Weed Real Estate Stock Proves Conservative Strategies Bring Returns
New Lake Capital Partners (OTC:NLCP), a real estate company focused on cannabis properties, offers an attractive investment with a 9.1% dividend yield, well above the return on 10-year government... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
85% Of Cannabis Companies Report Positive Earnings, But Not All Are Winning - See Who's Leading
85% of the companies analyzed by Beacon Securities achieved positive adjusted EBITDA for the quarter, an increase from 81% in Q2. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Is MariMed A Safe Haven In The Wake Of Florida's Cannabis Legalization Defeat?
For investors, MariMed represents a fundamentally strong outlier, but industry-wide challenges remain a drag on stock performance. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Pharma-Grade Cannabis Could Hit Walgreens & CVS—But Can The Industry Survive The FDA?
As the formal review process for rescheduling cannabis unfolds, industry players are closely watching its potential to transform the sector. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Florida To Award 22 New Cannabis Licenses After 18-Month Wait—Legal Battles Ahead?
Florida awards 22 new medical cannabis licenses after 18 months, potentially sparking legal battles as patient numbers exceed 880,000. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Federal Policy Could Add $3 Billion To Cannabis Industry: On Track To Reach $55 Billion By 2030
According to LeafLink, over the next 2-3 years, 5,000 non-MSO retailers are projected to open in key states, increasing store counts by 70%. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
80% Leverage, 5.5x EBITDA: Is Cresco The High-Risk, High-Reward Play Investors Need?
According to Z&A, its enterprise value (EV) to current sales ratio stands at 1.6x, lower than Curaleaf and Green Thumb, both at 2.2x. 
Via Benzinga
Trump's Pick for Attorney General Is No Matt Gaetz When It Comes To Cannabis Reform
Trump picks Pam Bondi as new attorney general nominee, shifting focus to her record. Bondi's tough stance on cannabis contrasts with the pro-reform views of former choice, Matt Gaetz. 
Via Benzinga
Topics Cannabis Government
Exposures Cannabis Political
Best And Worst Performing States For Cannabis Sales In 2024: YTD Winners & Losers
BDSA's October 2024 data highlights Maryland as the fastest-growing state for cannabis sales, with a year-to-date increase of 57.8%. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stocks Feel The Burn: Matt Gaetz Bows Out As Trump's Attorney General Nominee
The AdvisorShares Pure US Cannabis ETF (NYSEARCA: MSOS), often viewed as a benchmark for MSOs, dropped by -4.31%, closing at $4.56. 
Via Benzinga
Topics Cannabis ETFs Government
Exposures Cannabis Political
Trulieve Cannabis Execs Buy 26K Company Shares: What Does This Mean For Investors?
Trulieve execs purchase 26,000 shares amid stock drop. Insider buys spark speculation of undervaluation despite Florida setbacks. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Medical Marijuana Footprint Grows In Florida As Legalization Push Fizzles, And Other New Cannabis Stores
RISE Dispensaries, a cannabis retail chain owned by Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF), opened RISE Dispensary Orlando on Good Homes Road on Friday, Nov. 8. Located at 725 Good... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Ground Cannabis Dust Is A Hazardous Chemical, Confirms Massachusetts Regulator
Via Benzinga
Topics Cannabis
Exposures Cannabis
Trump Nominates Another Cannabis Supporter To Cabinet: Rep. Matt Gaetz For Attorney General
Donald Trump nominated Rep. Matt Gaetz as attorney general, who has supported cannabis legalization and proposed ending cannabis testing for military recruitment. 
Via Benzinga
Topics Cannabis Government
Exposures Cannabis Political
Does the Rejection of Top Marijuana Legalization Measures Doom the Pot Industry?
The American electorate seems to have turned against weed legal reform. 
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
Cannabis Stocks Plunged After Florida Legalization Failed: Rational Reaction Or Market Overreach?
Florida's failed adult-use cannabis vote led to a $2.6B loss in market cap. Was the market reaction justified? Earnings data adds uncertainty. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Hemp Market Surge: How New Regulations Could Impact Growth
Hemp industry regulatory changes in 2024 may impact delta-8 THC sales, spark market shifts, and intensify hemp vs. marijuana sector conflicts. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stocks: Is It Time To Buy The Dip After Elections And Legalization Setbacks?
After a post-election plunge, cannabis stocks are showing signs of recovery. We analyze Tilray, SNDL, Trulieve, MSOS – time to buy the dip? 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tilray, Trulieve And Other Cannabis Stocks Nosediving As Industry Faces New Wave Of Political Uncertainty
Cannabis stocks plunge as Florida's legalization fails and GOP Senate control tempers expectations for industry growth. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Florida's Cannabis Initiative Defeated: Trulieve CEO Kim Rivers, NFL's Ricky Williams And Others Respond
Florida's cannabis legalization bid, Amendment 3, narrowly missed the mark. Industry leaders pledge to keep pushing for future reform efforts. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Hemp Vs. Marijuana: Industry Tensions Rise Amid Rejection Of Cannabis Legalization In Florida, The Dakotas
Explore rising cannabis industry tensions as hemp companies clash with MSOs over market control, legalization rejections, and regulatory divides. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Reform Stumbles In 2024 Elections: A State-By-State Breakdown As Stocks Take A Hit
Florida and the Dakotas reject cannabis measures, while Nebraska approves medical cannabis and Dallas decriminalizes. Explore each state's path forward. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Florida's Recreational Marijuana Measure Flames Out -- but There Is a Silver Lining
The Sunshine State's long-awaited attempt to legalize personal-use cannabis falls short, but it's not all bad news. 
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
Cannabis Stocks React On Election Day, SNDL Surges While Trulieve Raised The Stakes
On Election Day, cannabis stocks had mixed results. SNDL soared with strong financials, while Trulieve's stock dropped while waiting Florida. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
DeSantis 'On Wrong Side Of History' Curaleaf Chair Says, As Governor Calls Trulieve 'Big Pharma On Steroids'
Boris Jordan, founder and executive chair of Curaleaf Holdings, criticizes Governor Ron DeSantis for his opposition to cannabis legalization in Florida. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
< Previous 1 2 3 4 5 6 7 8 9
...
41 42 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.